{
    "2020-02-20": [
        [
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：一致行动关系解除公司实际控制人由丁列明、YINXIANG WANG变更为丁列明 控制人变化",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "一致行动关系解除",
                        "实际控制人变更",
                        "丁列明"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "A股异动|贝达药业涨停BPI-28592药品临床试验申请获得受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "涨停",
                        "BPI-28592",
                        "临床试验申请受理"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "BPI-28592药品临床试验申请获得受理 贝达药业涨停",
                "features": {
                    "keywords": [
                        "BPI-28592",
                        "临床试验申请受理",
                        "贝达药业",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业大涨5.93%，领涨化学制药板块",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "大涨",
                        "化学制药板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "化学制药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}